| Variable | IG, N = 20 | CG, N = 18 | p |
|---|---|---|---|
| Age | 63.61 ± 8.5 | 62.5 ± 10.5 | 0.65 |
| Sex (male) | 29.0% | 30.6% | 0.89 |
| Body Mass Index (BMI) | 26.3 ± 5.4 | 26.4 ± 4.06 | 0.62 |
| Systolic Blood Pressure (SBP) | 138.8 ± 18.7 | 132.2 ± 16.4 | 0.068 |
| Diastolic Blood Pressure (DBP) | 86.51 ± 14.02 | 87.97 ± 10.2 | 0.63 |
| Heart Rate (HR) | 80.4.95 ± 14.7 | 75.83 ± 12.25 | 0.18 |
| Smoker | 23.8% | 25% | 0.93 |
| Diabetes Mellitus | 30% | 22.2% | 0.82 |
| Hypertension | 55% | 55.5% | 0.96 |
| History of CVA | 10% | 5.55% | 0.28 |
| CAD | 25% | 33.3% | 0.46 |
| Ace Inhibitor/ARB | 80% | 94% | 0.16 |
| CCB | 25% | 22.2% | 0.86 |
| Β Blocker | 90% | 94.4% | 0.88 |
| Statin | 75% | 77.78% | 0.98 |
| Digoxin | 10% | 5.6% | 0.64 |
| Warfarin | 80% | 88.8 | 0.68 |
| P Wave dispersion | 40.18 ± 24.28 | 40.7 ± 23.6 | 0.88 |
| P max | 119.3 ± 14.8 mm | 118.3 ± 9 mm | 0.84 |
| LAVI | 26.45 ± 2.85 | 24.48 ± 1.76 | 0.52 |
| Nytric Oxide | 33.7 ± 12.61 | 36.5 ± 14.34 | 0.35 |
| MDA | 1.53 ± 0.56 | 1.66 ± 0.43 | 0.28 |
| HsCRP | 2.99 ± 0.86 | 2.83 ± 1.13 | 0.49 |
| TNFα | 14.79 ± 1.98 | 13.28 ± 2.40 | 0.14 |
| IL‐1 | 14.82 ± 1.88 | 13.74 ± 1.26 | 0.14 |
| IL‐6 | 15.60 ± 2.17 | 14.46 ± 1.71 | 0.11 |
| PT | 12.20 ± 3.17 | 13.46 ± 2.41 | 0.61 |
| APTT | 23.20 ± 4.47 | 24.26 ± 3.61 | 0.62 |
| INR | 2.04 ± 1.17 | 2.26 ± 1.21 | 0.81 |
| Physical Functioning | 90.22 ± 9.79 | 88.11 ± 17.9 | 0.82 |
| Limitation To Physical Health | 86.5 ± 20.5 | 85.7 ± 34.5 | 0.64 |
| Limitation To Emotional Problem | 80.5 ± 27.72 | 80.95 ± 35.4 | 0.71 |
| Energy Fatigue | 78.78 ± 15.9 | 75.3 ± 19.69 | 0.68 |
| Emotional Well‐being | 82.77 ± 15.5 | 78.9 ± 16.15 | 0.165 |
| Social Functioning | 88.75 ± 15.1 | 83.6 ± 28.5 | 0.179 |
| Pain | 86.08 ± 24.1 | 83.19 ± 28.5 | 0.522 |
| General Health | 77.54 ± 14.3 | 79.55 ± 16.26 | 0.83 |
| Physical_Limitation | 79.25 ± 18.39 | 76.3 ± 19.9 | 0.176 |